Literature DB >> 2831925

Acute hepatic porphyria and hepatocellular carcinoma.

R Kauppinen1, P Mustajoki.   

Abstract

In this study we examined the case histories of 163 living and 82 deceased adult Finnish patients with acute hepatic porphyria. There were 184 patients with acute intermittent porphyria and 61 patients with variegate porphyria. Among the 124 of the 163 living patients, who were traced 1984-1985, no hepatocellular carcinoma was found. Among the 82 deceased patients the cause of death was porphyria in 29 (36%), cardiovascular disease in 23 (29%) and hepatocellular carcinoma in 7 (9%). Of the 7 patients with hepatocellular carcinoma, 6 had acute intermittent porphyria and one had variegate porphyria. In acute hepatic porphyria, as compared with the total population, the calculated risk of hepatocellular carcinoma is increased 61-fold.

Entities:  

Mesh:

Year:  1988        PMID: 2831925      PMCID: PMC2246695          DOI: 10.1038/bjc.1988.23

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Incidence of hepatoma in porphyria cutanea tarda.

Authors:  J BERMAN; A BRAUN
Journal:  Rev Czech Med       Date:  1962

2.  Frequency of occurrence of hepatocellular carcinoma in patients with porphyria cutanea tarda in long-term follow-up.

Authors:  V Kordac
Journal:  Neoplasma       Date:  1972       Impact factor: 2.575

3.  Association of porphyria cutanea tarda and primary liver cancer: report of ten cases.

Authors:  J A Solis; P Betancor; R Campos; R E Enriquez de Salamanca; P Rojo; I Marin; A Schüller
Journal:  J Dermatol       Date:  1982-04       Impact factor: 4.005

4.  Red cell uroporphyrinogen I synthetase in acute intermittent porphyria.

Authors:  P Mustajoki
Journal:  Ann Clin Res       Date:  1976

5.  Hereditary hepatic porphyrias in Finland.

Authors:  P Mustajoki; P Koskelo
Journal:  Acta Med Scand       Date:  1976

6.  Abnormalities in liver function and morphology and impaired aminopyrine metabolism in hereditary hepatic porphyrias.

Authors:  J Ostrowski; E Kostrzewska; T Michalak; B Zawirska; W Medrzejewski; A Gregor
Journal:  Gastroenterology       Date:  1983-11       Impact factor: 22.682

7.  The pathology of the liver in porphyria cutanea tarda.

Authors:  J M Cortés; H Oliva; F J Paradinas; C Hernandez-Guío
Journal:  Histopathology       Date:  1980-09       Impact factor: 5.087

8.  Hepatitis B and primary hepatocellular carcinoma in a European population.

Authors:  D Trichopoulos; E Tabor; R J Gerety; E Xirouchaki; L Sparros; N Munoz; C A Linsell
Journal:  Lancet       Date:  1978-12-09       Impact factor: 79.321

9.  Primary hepatocellular carcinoma--etiology, pathogenesis, and prevention.

Authors:  W T London
Journal:  Hum Pathol       Date:  1981-12       Impact factor: 3.466

10.  The UPS locus encoding uroporphyrinogen I synthase is located on human chromosome 11.

Authors:  M Meisler; L Wanner; R E Eddy; T B Shows
Journal:  Biochem Biophys Res Commun       Date:  1980-07-16       Impact factor: 3.575

View more
  19 in total

1.  Epidemiology and carcinogenesis of hepatocellular carcinoma.

Authors:  Trishe Y-M Leong; Anthony S-Y Leong
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

2.  The incidence of inherited porphyrias in Europe.

Authors:  George Elder; Pauline Harper; Michael Badminton; Sverre Sandberg; Jean-Charles Deybach
Journal:  J Inherit Metab Dis       Date:  2012-11-01       Impact factor: 4.982

3.  Non-viral factors contributing to hepatocellular carcinoma.

Authors:  Manal A Hamed; Sanaa A Ali
Journal:  World J Hepatol       Date:  2013-06-27

Review 4.  Hepatocellular carcinoma: epidemiology, screening, and assessment of hepatic reserve.

Authors:  S Z Frager; J M Schwartz
Journal:  Curr Oncol       Date:  2020-11-01       Impact factor: 3.677

5.  Occurrence of Malignant Tumours in the Acute Hepatic Porphyrias.

Authors:  Estefanía Lang; Martin Schäfer; Holger Schwender; Norbert J Neumann; Jorge Frank
Journal:  JIMD Rep       Date:  2015-02-22

6.  Dimethyl sulfoxide and ebselen prevent convulsions induced by 5-aminolevulinic acid.

Authors:  Carlos André Prauchner; Adriano Neujahr Agostini; Akemi Morimoto; Paula Rossini Augusti; Taís Cristina Unfer; Gilson Zeni; Carlos Fernando Mello; Tatiana Emanuelli
Journal:  Neurochem Res       Date:  2004-10       Impact factor: 3.996

7.  Melatonin prevents delta-aminolevulinic acid-induced oxidative DNA damage in the presence of Fe2+.

Authors:  W Qi; R J Reiter; D X Tan; L C Manchester; J R Calvo
Journal:  Mol Cell Biochem       Date:  2001-02       Impact factor: 3.396

8.  High risk of primary liver cancer in a cohort of 179 patients with Acute Hepatic Porphyria.

Authors:  Eliane Sardh; Staffan Wahlin; Mikael Björnstedt; Pauline Harper; Dan E H Andersson
Journal:  J Inherit Metab Dis       Date:  2013-01-23       Impact factor: 4.982

Review 9.  New advances in hepatocellular carcinoma.

Authors:  Sonia Pascual; Iván Herrera; Javier Irurzun
Journal:  World J Hepatol       Date:  2016-03-28

10.  Increased porphyrins in primary liver cancer mainly reflect a parallel liver disease.

Authors:  Jerzy Kaczynski; Göran Hansson; Sven Wallerstedt
Journal:  Gastroenterol Res Pract       Date:  2009-10-18       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.